Jefferies Group LLC Anavex Life Sciences Corp. Put Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	SELL	$7.31 - $12.84 $173,978 - $305,592	-23,800 Reduced 32.25%	50,000 $500,000
Q2 2022 Aug 15, 2022	BUY	$7.31 - $12.84 $365,500 - $642,000	50,000 New	50,000 $501,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.69 $718,812 - $1.31 Million	-73,800 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$16.88 - $23.31 $401,744 - $554,778	23,800 Added 47.6%	73,800 $1.28 Million
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $1.25 Million - $1.72 Million	73,800 New	73,800 $1.28 Million

155

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.